Skip NavigationSkip to Content

Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin disorders

  1. Author:
    Waghule, Tejashree
    Rapalli, Vamshi Krishna
    Gorantla, Srividya
    Saha, Ranendra Narayan
    Dubey, Sunil Kumar
    Puri,Anu
    Singhvi, Gautam
  2. Author Address

    Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus. India., National Cancer Institute at Frederick, National Institutes of Health. United States.,
    1. Year: 2020
    2. Date: Jun 14
    3. Epub Date: 2020 06 14
  1. Journal: Current pharmaceutical design
    1. 26
    2. 36
    3. Pages: 4569-4579
  2. Type of Article: Article
  1. Abstract:

    Background: Skin diseases affect all the age groups of people and have impact on patients' physical, mental and emotional status. Conventional topical preparation are limited with its efficacy due to low permeation, frequent application and poor adherence to the therapy for prolong time. Objective: The objective of this review article is to address the emerging trends of nanotechnology derived lipidic carrier systems for effective treatment for skin disorders. Methodology: Various research and review articles from reputed international journals were referred and compiled. Results and discussion: Topical drug delivery systems are found to be more effective than oral and parenteral drug delivery systems for treating skin diseases due to targeted localized applications with reduced side effects. Lipid-based nanoparticles have been found to have the potential in treating skin diseases due to the biocompatibility and the versatility of the lipids. Nanostructured lipid carriers (NLCs) have gained much attention in treating skin diseases due to improved stability of the drugs, enhanced skin permeation, retention, and better therapeutic efficacy. The review summarizes the NLCs characteristics and their application for topical delivery of various therapeutics in skin disorders. NLCs have shown great potential in the effective drug delivery for the treatment of psoriasis, dermatitis, bacterial infections, and skin cancer. Its cosmetic application has opened new area for skincare. Further, safety and clinical status revealed its future commercial acceptability. Conclusion: NLCs have been found as effective lipid nanocarriers for delivery of topical therapeutics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

    See More

External Sources

  1. DOI: 10.2174/1381612826666200614175236
  2. PMID: 32534562
  3. WOS: 000582502400005
  4. PII : CPD-EPUB-107347

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel